Overall read
Generally coherent
Selected: Semax, Selank, 9-ME-BC, Adamax. This is a triage layer, not a dosing or safety clearance.
The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.
Interaction intelligence
Select up to eight compounds and review known synergies, redundancies, cautions, and unknowns. Unknown is shown honestly instead of guessed.
Overall read
Selected: Semax, Selank, 9-ME-BC, Adamax. This is a triage layer, not a dosing or safety clearance.
Selank is primarily framed around anxiolytic/stress and immune-neuropeptide effects, while Semax is framed around nootropic/neurotrophic ACTH-fragment effects. The intended use cases can complement each other.
Confidence: community · Evidence: Community/nootropic practice plus mechanism distinction; direct controlled combination data absent.
Caution: Monitor stimulation, sleep, anxiety response, and route-specific tolerability.
Source/rationale: Nootropic peptide community rationale
No interaction data — community use appears common but no published data exists for this combination.
Confidence: unknown · Evidence: No pair-specific source/rationale in the current interaction dataset.
Source/rationale: Fallback: unknown pair
Some community sources describe 'Adamax' as simply a blend of Semax and Selank — creating confusion about whether Adamax should be combined with additional Semax.
Confidence: community · Evidence: Documented in the Adamax chapter's stacking discussion (community practice; not a controlled combination trial).
Source/rationale: chapter:adamax §9
No interaction data — community use appears common but no published data exists for this combination.
Confidence: unknown · Evidence: No pair-specific source/rationale in the current interaction dataset.
Source/rationale: Fallback: unknown pair
The community's most common combination: Semax-type compound (stimulatory, focus-enhancing, BDNF-driven) paired with Selank-type compound (anxiolytic, GABAergic, anti-stress).
Confidence: community · Evidence: Documented in the Adamax chapter's stacking discussion (community practice; not a controlled combination trial).
Source/rationale: chapter:adamax §9
No interaction data — community use appears common but no published data exists for this combination.
Confidence: unknown · Evidence: No pair-specific source/rationale in the current interaction dataset.
Source/rationale: Fallback: unknown pair